These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6330644)

  • 1. [Transplacental passage of cefmenoxime].
    Berthelot G; Bergogne-Berezin E; Ravina JH; Vernant D; Bryskier A
    Pathol Biol (Paris); 1984 May; 32(5):322-5. PubMed ID: 6330644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental transfer of cefmenoxime in late pregnancy.
    Bergogne-Bérézin E; Bryskier A; Berthelot G; Ravina JH; Vernant D
    Chemotherapy; 1985; 31(1):1-5. PubMed ID: 3855746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of the transplacental passage of cefotaxime (author's transl)].
    Pierre J; Bergogne-Berezin E; Ravina J; Vernant D
    Nouv Presse Med; 1981 Feb; 10(8):587-9. PubMed ID: 6259598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Placental passage of cefodizime].
    Berthelot G; Bornet M; Bergogne-Bérézin E; Ravina JH
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):699-701. PubMed ID: 3054750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical results and concentrations of cefmenoxime in serum, amniotic fluid, mother's milk, and umbilical cord.
    Weissenbacher ER; Adams D; Gutschow K; Peters-Welte C; Luehr HG
    Am J Med; 1984 Dec; 77(6A):11-2. PubMed ID: 6097116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study on cefmenoxime (CMX) in urology].
    Tanaka H; Kato Y; Kakinoki K; Nishio S; Maekawa M; Tsujita M; Nishijima T; Kashihara N; Kono S; Hayahara N
    Hinyokika Kiyo; 1983 Jan; 29(1):95-103. PubMed ID: 6328956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the diffusion of cefmenoxime into the bronchial secretions.
    Serieys C; Bergogne-Berezin E; Kafe H; Bryskier A
    Chemotherapy; 1986; 32(1):1-6. PubMed ID: 3456295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefmenoxime therapy for gynecologic and obstetric infections.
    Rao B; Savage EW; Chuah SK; Bansal MB; Dhawan VK; Thadepalli H
    Obstet Gynecol; 1985 Sep; 66(3):377-83. PubMed ID: 3860790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diffusion of aztreonam in the tissues and biological fluids of the female genital tract].
    Berthelot G; Bergogne-Bérézin E; Vernant D; Ravina JH
    Pathol Biol (Paris); 1986 May; 34(5):339-41. PubMed ID: 3534702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid.
    Mihailović M; Cvetković M; Ljubić A; Kosanović M; Nedeljković S; Jovanović I; Pesut O
    Biol Trace Elem Res; 2000 Jan; 73(1):47-54. PubMed ID: 10949968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women.
    Mandelbrot L; Peytavin G; Firtion G; Farinotti R
    Am J Obstet Gynecol; 2001 Jan; 184(2):153-8. PubMed ID: 11174495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus.
    Chappuy H; Tréluyer JM; Rey E; Dimet J; Fouché M; Firtion G; Pons G; Mandelbrot L
    Am J Obstet Gynecol; 2004 Aug; 191(2):558-62. PubMed ID: 15343237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic and clinical studies of cefotiam in the perinatal period].
    Yamamoto T; Yasuda J; Kanao M; Okada H
    Jpn J Antibiot; 1986 Sep; 39(9):2525-33. PubMed ID: 3467093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g].
    Veyssier P; Bryskier A; Modai J; Boquet A; Fourtillan JB
    Pathol Biol (Paris); 1986 Dec; 34(10):1081-3. PubMed ID: 3547264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic study of cefmenoxime concerning its transfer into tissues].
    Washida H; Tsugaya M; Hirao N; Sakagami H; Iwase Y
    Jpn J Antibiot; 1985 Jun; 38(6):1648-53. PubMed ID: 3862883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of leptin and neuropeptide Y in maternal plasma, umbilical cord blood and in amniotic fluid in pregnant women with EPH-gestosis.
    Kokot F; Ulman I; Wiecek A; Irzyniec T; Ulman J
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):311-6. PubMed ID: 9832071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with cefotaxime in gynecology and obstetrics.
    Takase Z
    Clin Ther; 1981; 4 Suppl A():25-44. PubMed ID: 6275996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylactic effects of cefmenoxime against postoperative infections after thoracotomy. Studies of cefmenoxime transfer from serum to pleural fluid and of clinical effects of cefmenoxime].
    Matsuura Y; Yamashina H; Higo M; Fujii T; Yamamoto M; Shimamoto H
    Jpn J Antibiot; 1987 Feb; 40(2):295-302. PubMed ID: 3474428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cefmenoxime diffusion into cerebrospinal fluid during human purulent meningitis].
    Stahl JP; Croize J; Bru JP; Pegourie B; Blanc-Jouvan F; Bryskier A; Micoud M
    Pathol Biol (Paris); 1985 May; 33(5):365-7. PubMed ID: 3897967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transfer of cefmenoxime to burn blister fluids].
    Nishizaki A; Aoyama H; Koh T; Izawa Y
    Jpn J Antibiot; 1984 Mar; 37(3):295-302. PubMed ID: 6330396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.